These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 26275808

  • 21. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
    Rose T, Grützkau A, Hirseland H, Huscher D, Dähnrich C, Dzionek A, Ozimkowski T, Schlumberger W, Enghard P, Radbruch A, Riemekasten G, Burmester GR, Hiepe F, Biesen R.
    Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
    [Abstract] [Full Text] [Related]

  • 22. Serum levels of CXCL5 are decreased and correlate with circulating platelet counts in systemic lupus erythematosus.
    Zhang L, Zhao L, Du K, Chen J, Ding H, Petersen F, Ye S, Lin Z, Yu X.
    Int J Rheum Dis; 2024 Mar; 27(3):e15089. PubMed ID: 38439196
    [Abstract] [Full Text] [Related]

  • 23. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
    Katoh S, Fukushima K, Matsumoto N, Ehara N, Matsumoto K, Yamauchi A, Hirashima M.
    Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791
    [Abstract] [Full Text] [Related]

  • 24. PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus.
    Luo Q, Huang Z, Ye J, Deng Y, Fang L, Li X, Guo Y, Jiang H, Ju B, Huang Q, Li J.
    Arthritis Res Ther; 2016 Feb 11; 18():47. PubMed ID: 26867643
    [Abstract] [Full Text] [Related]

  • 25. Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus.
    Ferreira GA, Teixeira AL, Sato EI.
    Lupus; 2010 Jul 11; 19(8):927-34. PubMed ID: 20410153
    [Abstract] [Full Text] [Related]

  • 26. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F, Zimmermann HW, Berres ML, Trautwein C, Wasmuth HE.
    Liver Int; 2011 Jul 11; 31(6):840-9. PubMed ID: 21645215
    [Abstract] [Full Text] [Related]

  • 27. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
    Berres ML, Trautwein C, Schmeding M, Eurich D, Tacke F, Bahra M, Neuhaus P, Neumann UP, Wasmuth HE.
    Hepatology; 2011 Feb 11; 53(2):596-603. PubMed ID: 21274880
    [Abstract] [Full Text] [Related]

  • 28. Angiostatic versus angiogenic chemokines in IPF and EAA.
    Martina S, Martina V, Monika M, Jan P, Libor K, Ilja S.
    Respir Med; 2009 Nov 11; 103(11):1651-6. PubMed ID: 19535235
    [Abstract] [Full Text] [Related]

  • 29. Differential expression of the inflammation-associated chemokines/cytokines in mouse lung after exposure to cigarette smoke and smoking cessation.
    Li JR, Zhou WX, Zhao ZX, Gao JM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Jun 11; 36(3):241-8. PubMed ID: 24997814
    [Abstract] [Full Text] [Related]

  • 30. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
    Enocsson H, Wetterö J, Eloranta ML, Gullstrand B, Svanberg C, Larsson M, Bengtsson AA, Rönnblom L, Sjöwall C.
    Front Immunol; 2021 Jun 11; 12():688753. PubMed ID: 34276678
    [Abstract] [Full Text] [Related]

  • 31. CXCL9/CXCL10 angiostasis CXC-chemokines in parallel with the CXCL12 as an angiogenesis CXC-chemokine are variously expressed in pre-eclamptic-women and their neonates.
    Darakhshan S, Hassanshahi G, Mofidifar Z, Soltani B, Karimabad MN.
    Pregnancy Hypertens; 2019 Jul 11; 17():36-42. PubMed ID: 31487653
    [Abstract] [Full Text] [Related]

  • 32. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
    Cai M, Bonella F, He X, Sixt SU, Sarria R, Guzman J, Costabel U.
    Respir Med; 2013 Sep 11; 107(9):1444-52. PubMed ID: 23831213
    [Abstract] [Full Text] [Related]

  • 33. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
    Yin X, Wang Z, Wu T, Ma M, Zhang Z, Chu Z, Hu Q, Ding H, Han X, Xu J, Shang H, Jiang Y.
    J Transl Med; 2019 Dec 13; 17(1):417. PubMed ID: 31836011
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM, Marx AS, Barry NN.
    J Rheumatol; 2000 Mar 13; 27(3):664-70. PubMed ID: 10743805
    [Abstract] [Full Text] [Related]

  • 35. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA, El-Gendi HI, Ahmed HH.
    Clin Biochem; 2005 Feb 13; 38(2):134-41. PubMed ID: 15642275
    [Abstract] [Full Text] [Related]

  • 36. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
    Rudloff I, Godsell J, Nold-Petry CA, Harris J, Hoi A, Morand EF, Nold MF.
    Arthritis Rheumatol; 2015 Dec 13; 67(12):3219-25. PubMed ID: 26314375
    [Abstract] [Full Text] [Related]

  • 37. Elevated circulating levels of the interferon-γ-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease.
    Han JH, Suh CH, Jung JY, Ahn MH, Han MH, Kwon JE, Yim H, Kim HA.
    Sci Rep; 2017 Apr 24; 7():46652. PubMed ID: 28436448
    [Abstract] [Full Text] [Related]

  • 38. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.
    J Autoimmun; 2008 Dec 24; 31(4):372-6. PubMed ID: 18926664
    [Abstract] [Full Text] [Related]

  • 39. CX3CR1 might be a promising predictor of systemic lupus erythematosus patients with pulmonary fibrosis.
    Qiu F, Li Y, Zhu Y, Li G, Lei F, Zhang S, Luo L, Zhu J, Guo Y, Du B, Xi X.
    Scand J Immunol; 2021 Jul 24; 94(1):e13038. PubMed ID: 33665864
    [Abstract] [Full Text] [Related]

  • 40. Characteristics of Proinflammatory Cytokines and Chemokines in Airways of Asthmatics: Relationships with Disease Severity and Infiltration of Inflammatory Cells.
    Yang T, Li Y, Lyu Z, Huang K, Corrigan CJ, Ying S, Wang W, Wang C.
    Chin Med J (Engl); 2017 Sep 05; 130(17):2033-2040. PubMed ID: 28836545
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.